CD79A and myeloid sarcoma: The decreased level of B‐cell linker protein (BLNK), CD40 and CD210 expression in untreated patients with MS likely influences the function of various B‐cell subsets, including potentially protective roles of immunoglobulin (Ig)A+CD20+ B cells and detrimental IgG1+ B cells.